Indications and uses
• temporarily relieves nasal congestion due to: • common cold • hay fever • upper respiratory allergies • temporarily relieves sinus congestion and pressure • shrinks swollen nasal membranes so you can breathe more freely
Dolgencorp, LLC Nasal Spray Drug Facts
- Manufacturer
- Dolgencorp, LLC
- Effective date
- 2024-10-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 20:53:45
Label at a glance#
Productrexall nasal
Active ingredientOXYMETAZOLINE HYDROCHLORIDE
Label structure9 sections
Dosage and administration
• adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period. • children under 6 years of age: ask a doctor To Use: Push firmly down on cap and turn counter clockwise. To spray, squeeze bottle quickly and firmly. Do not tilt head backward while spraying. Wipe nozzle clean after use. Sec...
Storage and handling
• store at 20-25°C (68-77°F) • retain carton for future reference on full labeling
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredient
Oxymetazoline hydrochloride 0.05%
Purpose
Nasal decongestant
Uses
- temporarily relieves nasal congestion due to:
- common cold
- hay fever
- upper respiratory allergies
- temporarily relieves sinus congestion and pressure
- shrinks swollen nasal membranes so you can breathe more freely
Warnings
Ask a doctor before use if you have
- heart disease
- high blood pressure
- diabetes
- thyroid disease
- trouble urinating due to an enlarged prostate gland
When using this product
- do not use more than directed
- do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
- temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge may occur
- use of this container by more than one person may spread infection
Stop use and ask a doctor if
symptoms persist
If pregnant or breast-feeding,
ask a health professional before use.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
Directions
- adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
- children under 6 years of age: ask a doctor
To Use: Push firmly down on cap and turn counter clockwise. To spray, squeeze bottle quickly and firmly. Do not tilt head backward while spraying. Wipe nozzle clean after use. Secure cap after use.
Other information
- store at 20-25°C (68-77°F)
- retain carton for future reference on full labeling
Inactive ingredients
benzalkonium chloride solution, benzyl alcohol, dibasic sodium phosphate, edetate disodium, glycerin, monobasic sodium phosphate, polyethylene glycol, povidone, propylene glycol, purified water
Questions or comments?
1-866-4-REXALL
Principal Display Panel
Extra Moisturizing
Nasal Spray
Oxymetazoline Hydrochloride 0.05%
12 HOUR RELIEF
Nasal Decongestant For Colds & Allergies
Fast, Powerful Congestion Relief
Soothes And Helps Rehydrate Dry Noses
1 FL OZ (30 mL)
Products#
Every source-derived product name is available through these pages.
- rexall nasal
- Oxymetazoline Hydrochloride
- OXYMETAZOLINE
- BENZALKONIUM CHLORIDE
- BENZYL ALCOHOL
- SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM
- EDETATE DISODIUM
- GLYCERIN
- SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
- POLYETHYLENE GLYCOL, UNSPECIFIED
- POVIDONE, UNSPECIFIED
- PROPYLENE GLYCOL
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55910-507 | 55910-507-10 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0139d002-8005-4f5a-ba6a-4d13aa589303 | fe433609-e3f8-4ea6-8282-ca2871bfaf0f | 2024-10-02 | Warnings | 0139d002-8005-4f5a-ba6a-4d13aa589303 fe433609-e3f8-4ea6-8282-ca2871bfaf0f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.